Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Avi Kapoor

This Eli Lilly Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday

Eli Lilly

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Scotiabank analyst Nicholas Yulico upgraded Prologis, Inc. (NYSE:PLD) from Sector Underperform to Sector Perform and raised the price target from $100 to $114. Prologis shares closed at $111.35 on Tuesday. See how other analysts view this stock.
  • HSBC analyst Akshay Gupta upgraded the rating for Amer Sports, Inc. (NYSE:AS) from Hold to Buy and boosted the price target from $38 to $50. Amer Sports shares closed at $40.71 on Tuesday. See how other analysts view this stock.
  • HSBC analyst Rajesh Kumar upgraded Eli Lilly and Company (NYSE:LLY) from Reduce to Hold and raised the price target from $675 to $700. Eli Lilly shares closed at $736.03 on Tuesday. See how other analysts view this stock.
  • B of A Securities analyst Geoff Meacham upgraded Vir Biotechnology, Inc. (NASDAQ:VIR) from Neutral to Buy and raised the price target from $12 to $14. Vir Biotechnology shares closed at $4.44 on Tuesday. See how other analysts view this stock.

Considering buying LLY stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.